Assistance Publique - Hôpitaux de Marseille
Marseille, 13005, France
NCT Number: NCT03356366
Multiple sclerosis (MS) is the first non-traumatic cause of disability in young people, responsible for physical but also cognitive deficits. MS is an inflammatory demyelinating and degenerative disease of the central nervous system. Recently, MRI technics have demonstrated their sensibility to the different processes involved in MS. Particularly, MRI has evidenced that the pathological process of MS is not restricted to the macroscopic lesions of the white matter but also involves the normal appearing white and grey matter. In the normal appearing brain tissue, demyelination, neuronal suffering and neuronal loss have been evidenced. Moreover, MRI has demonstrated the existence of brain functional reorganization processes that may limit the clinical expression of pathological injuries. Despite these important findings, the pathological underpinnings of irreversible disability are largely unknown. The present project aims to depict the main determinants of physical but also cognitive disability in patients with MS. To do this, a longitudinal study including 70 patients with MS using different MRI markers known to be sensitive to the different pathological aspects of MS will be performed. The relationships between these markers and the progression of disability will be assessed. Identification of the main pathological underpinnings of irreversible disability of MS will provide the most relevant therapeutic targets.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Marseille, 13005, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Magnetic Resonance Imaging 3 Tesla
Magnetic Resonance Imaging 1,5 Tesla
Magnetic Resonance Imaging 7 Tesla
Time frame: 5 years
Assistance Publique Hopitaux De Marseille
Other
Magnetic Resonance Imaging Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis
Acronym: SEP-MRI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04544436
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Cullman, Alabama, United States
View Trial DetailsNCT04548999
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Homewood, Alabama, United States
View Trial DetailsNCT06141473
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Birmingham, Alabama, United States
View Trial DetailsNCT07705581
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Graz, Austria
View Trial Details